Mar 16, 2023 07:00AM
Mar 16, 2023 07:00AM
Feb 1, 2023 07:33AM
Feb 1, 2023 07:30AM
Feb 1, 2023 07:30AM
Jan 11, 2023 04:15PM
Nov 14, 2022 05:27PM Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights
Nov 14, 2022 05:27PM
Feb 28, 2022 09:00AM
Feb 28, 2022 06:01AM
Feb 28, 2022 06:00AM
Feb 28, 2022 06:00AM
Oct 28, 2021 07:00AM
Oct 28, 2021 07:00AM Evelo Biosciences Reports Third Quarter 2021 Financial Results and Business Highlights
Sep 1, 2021 01:44PM
Jul 14, 2021 04:01PM
Jul 14, 2021 04:01PM
Jan 20, 2021 09:20AM
Oct 13, 2020 07:05AM
Oct 13, 2020 07:00AM
Oct 13, 2020 07:00AM Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis
Jul 30, 2020 07:00AM
Jul 30, 2020 07:00AM
Jul 28, 2020 11:31AM
Jun 25, 2020 09:26AM
Jun 22, 2020 09:31AM
Jun 22, 2020 06:03AM
Jun 22, 2020 02:00AM Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial
Jun 22, 2020 02:00AM
May 7, 2020 09:25AM
Feb 13, 2020 07:00AM
Feb 13, 2020 07:00AM
Jan 10, 2020 07:08AM
Jan 10, 2020 07:00AM
Jan 10, 2020 07:00AM Evelo Provides Update on Recent Positive EDP1815 Regulatory Interactions on Phase 2 Trial Design Resulting in Shorter Development Timeline to Registration
Nov 19, 2019 04:30PM
Nov 8, 2019 07:00AM
Oct 2, 2019 07:00AM
Aug 2, 2018 08:00AM
Aug 2, 2018 08:00AM
May 31, 2018 08:00AM
May 31, 2018 08:00AM Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All